Literature DB >> 26769461

Coffee consumption and risk of levodopa-induced dyskinesia in Parkinson's disease: The FRAGAMP study.

Alessandra Nicoletti1, Mario Zappia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26769461     DOI： 10.1002/mds.26459

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  8 in total

1.  Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease.

Authors:  Angelo Fabio Gigante; Artor Niccoli Asabella; Giovanni Iliceto; Tommaso Martino; Cristina Ferrari; Giovanni Defazio; Giuseppe Rubini
Journal:  Neurol Sci       Date:  2018-01-23       Impact factor: 3.307

Review 2.  Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.

Authors:  Tai N Tran; Trang N N Vo; Karen Frei; Daniel D Truong
Journal:  J Neural Transm (Vienna)       Date:  2018-07-03       Impact factor: 3.575

3.  Head trauma and Parkinson's disease: results from an Italian case-control study.

Authors:  Alessandra Nicoletti; Rosario Vasta; Giovanni Mostile; Giuseppe Nicoletti; Gennarina Arabia; Giovanni Iliceto; Paolo Lamberti; Roberto Marconi; Letterio Morgante; Paolo Barone; Aldo Quattrone; Mario Zappia
Journal:  Neurol Sci       Date:  2017-07-26       Impact factor: 3.307

Review 4.  Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?

Authors:  Jiang-Fan Chen; Michael A Schwarzschild
Journal:  Parkinsonism Relat Disord       Date:  2020-12-19       Impact factor: 4.891

5.  Cognitive impairment and levodopa induced dyskinesia in Parkinson's disease: a longitudinal study from the PACOS cohort.

Authors:  Antonina Luca; Roberto Monastero; Roberta Baschi; Calogero Edoardo Cicero; Giovanni Mostile; Marco Davì; Vincenzo Restivo; Mario Zappia; Alessandra Nicoletti
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 6.  Life style and Parkinson's disease.

Authors:  Heinz Reichmann; Ilona Csoti; Jiri Koschel; Stefan Lorenzl; Christoph Schrader; Juergen Winkler; Ullrich Wüllner
Journal:  J Neural Transm (Vienna)       Date:  2022-05-23       Impact factor: 3.850

7.  Kahweol decreases hepatic fibrosis by inhibiting the expression of connective tissue growth factor via the transforming growth factor-beta signaling pathway.

Authors:  Hye-Young Seo; Yun-A Jung; So-Hee Lee; Jae Seok Hwang; Keun-Gyu Park; Mi-Kyung Kim; Byoung Kuk Jang
Journal:  Oncotarget       Date:  2017-08-01

8.  Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review.

Authors:  Jikke T Boelens Keun; Ilse Ac Arnoldussen; Chris Vriend; Ondine van de Rest
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.